Emoke Racz
Research Subjects
Research Interests
Emoke Racz has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Sarolta Kárpáti
Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary
3 shared publications A. Horváth
Semmelweis University, Department of Dermato‐Venereology, Budapest, Hungary
1 shared publicationM Csikós
Department of Dermatology 2 2nd
1 shared publicationM Dobos
1 shared publicationM. Csikos
Department of Dermato‐Venereology, Semmelweis University, Budapest, Hungary; and Dermatological Research Group of Genetics and Immunology, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary
1 shared publicationM. Csikós
Semmelweis University, Department of Dermato‐Venereology, Budapest, Hungary
1 shared publication
Latest Publications
- Open Access
- 6 April 2006
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 86 (1) , 59-60
Darier's disease associated with cutis verticis gyrata, hyperprolactinaemia and depressive disorder
- 6 April 2006
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 86 (1) , 59-60
Open AccessDarier's disease associated with cutis verticis gyrata, hyperprolactinaemia and depressive disorder
- 1 September 2005
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 30 (5) , 575-577
Novel mutations in the ATP2C1 gene in two patients with Hailey-Hailey disease
Benign familial chronic pemphigus (Hailey-Hailey disease, HHD) is a rare hereditary condition characterized by development of blisters at sites of friction and in the intertriginous areas. Mutations in the ATP2C1 gene, which encodes the human secretory pathway calcium ATPase 1 (hSPCA1), have been identified as possible causative mutations. Studying Hungarian patients with HHD, we found two novel, distinct, heterozygous mutations. In a 65-year-old man with a 41-year history of severe recurrent symptoms, a single nucleotide insertion, 1085insA, was detected. In a patient whose symptoms were induced by environmental contact allergens, we found a nonsense mutation, Q506X, in exon 17. Our study further illustrates the diversity of mutational events in the pathogenesis of HHD.
- 1 September 2005
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 30 (5) , 575-577
Novel mutations in the ATP2C1 gene in two patients with Hailey-Hailey disease
Benign familial chronic pemphigus (Hailey-Hailey disease, HHD) is a rare hereditary condition characterized by development of blisters at sites of friction and in the intertriginous areas. Mutations in the ATP2C1 gene, which encodes the human secretory pathway calcium ATPase 1 (hSPCA1), have been identified as possible causative mutations. Studying Hungarian patients with HHD, we found two novel, distinct, heterozygous mutations. In a 65-year-old man with a 41-year history of severe recurrent symptoms, a single nucleotide insertion, 1085insA, was detected. In a patient whose symptoms were induced by environmental contact allergens, we found a nonsense mutation, Q506X, in exon 17. Our study further illustrates the diversity of mutational events in the pathogenesis of HHD.
- 30 June 2005
- Published by Elsevier in Journal of Dermatological Science
- Vol. 38 (3) , 231-234
Three novel mutations in the ATP2A2 gene in Hungarian families with Darier's disease, including a novel splice site generating intronic nucleotide change
- 30 June 2005
- Published by Elsevier in Journal of Dermatological Science
- Vol. 38 (3) , 231-234
Three novel mutations in the ATP2A2 gene in Hungarian families with Darier's disease, including a novel splice site generating intronic nucleotide change
- 1 June 2004
- Published by Wiley in Experimental Dermatology
- Vol. 13 (6) , 396-399
Identification of mutations in the ATP2A2 gene in patients with Darier's disease from Hungary
Abstract: Mutation analysis in the ATP2A2 gene had been performed in eight Hungarian patients with Darier's disease (DD), to get more information about phenotype–genotype relations. All patients had moderate to severe skin symptoms. Polymerase chain reaction (PCR) amplification of the entire coding region of ATP2A2 was performed. Mutation detection strategies included heteroduplex scanning by conformation‐sensitive gel electrophoresis (CSGE) and direct nucleotide sequencing. We found distinct, heterozygous mutations (five missense, one nonsense, one deletion, and one insertion), six of which were novel. In a 31‐year‐old DD woman with learning difficulties we disclosed a previously described missense mutation (D702N) in exon 15. A 44‐year‐old DD woman had a novel T insertion at nucleotide 559 in exon 7 of the ATP2A2 gene, which resulted in a premature termination codon (PTC) at codon 192. A woman, whose skin symptoms developed unusually late, at the age 50, had a new T deletion (1320delT) in exon 11 resulting in a PTC at codon 448. Our most severe case had a known missense mutation N39T, resulting in a non‐conservative amino acid change at the upstream stalk region. Three new missense mutations (A161D, R164S, and Q790P) affected conservative regions of the SERCA2 protein within the activation (A)‐domain and the M6 transmembrane region. A further new nonsense mutation (C909X) was detected in the M8 transmembrane domain. Our data suggest that differences in DD phenotypes are probably also related to factors different from the type of causative mutation.
- 1 June 2004
- Published by Wiley in Experimental Dermatology
- Vol. 13 (6) , 396-399
Identification of mutations in the ATP2A2 gene in patients with Darier's disease from Hungary
Abstract: Mutation analysis in the ATP2A2 gene had been performed in eight Hungarian patients with Darier's disease (DD), to get more information about phenotype–genotype relations. All patients had moderate to severe skin symptoms. Polymerase chain reaction (PCR) amplification of the entire coding region of ATP2A2 was performed. Mutation detection strategies included heteroduplex scanning by conformation‐sensitive gel electrophoresis (CSGE) and direct nucleotide sequencing. We found distinct, heterozygous mutations (five missense, one nonsense, one deletion, and one insertion), six of which were novel. In a 31‐year‐old DD woman with learning difficulties we disclosed a previously described missense mutation (D702N) in exon 15. A 44‐year‐old DD woman had a novel T insertion at nucleotide 559 in exon 7 of the ATP2A2 gene, which resulted in a premature termination codon (PTC) at codon 192. A woman, whose skin symptoms developed unusually late, at the age 50, had a new T deletion (1320delT) in exon 11 resulting in a PTC at codon 448. Our most severe case had a known missense mutation N39T, resulting in a non‐conservative amino acid change at the upstream stalk region. Three new missense mutations (A161D, R164S, and Q790P) affected conservative regions of the SERCA2 protein within the activation (A)‐domain and the M6 transmembrane region. A further new nonsense mutation (C909X) was detected in the M8 transmembrane domain. Our data suggest that differences in DD phenotypes are probably also related to factors different from the type of causative mutation.